Squarepoint Ops LLC Allogene Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$96.1 Billion
Q3 2025

A detailed history of Squarepoint Ops LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 268,044 shares of ALLO stock, worth $329,694. This represents 0.0% of its overall portfolio holdings.

Number of Shares

268,044

Previous 18,066 1383.69%

Holding current value

$329,694

Previous $20,000 1560.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.03 - $1.66 $257,477 - $414,963	249,978 Added 1383.69%	268,044 $332,000
Q2 2025 Aug 27, 2025	SELL	$0.95 - $1.7 $293,036 - $524,380	-308,459 Reduced 94.47%	18,066 $20,000
Q2 2025 Aug 14, 2025	SELL	$0.95 - $1.7 $293,036 - $524,380	-308,459 Reduced 94.47%	18,066 $20,000
Q1 2025 Aug 27, 2025	BUY	$1.4 - $2.84 $431,842 - $876,023	308,459 Added 1707.4%	326,525 $476,000
Q1 2025 May 15, 2025	BUY	$1.4 - $2.84 $428,652 - $869,551	306,180 Added 1504.94%	326,525 $476,000

Q4 2024 Feb 14, 2025	SELL	$1.84 - $3.22 $309,399 - $541,449	-168,152 Reduced 89.21%	20,345 $43,000
Q3 2024 Nov 14, 2024	BUY	$2.08 - $3.5 $128,687 - $216,541	61,869 Added 48.86%	188,497 $527,000
Q2 2024 Aug 14, 2024	BUY	$2.23 - $4.38 $282,380 - $554,630	126,628 New	126,628 $295,000
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $30,976 - $46,088	-6,838 Reduced 12.04%	49,937 $248,000
Q1 2023 May 15, 2023	SELL	$4.92 - $8.21 $706,457 - $1.18 Million	-143,589 Reduced 71.66%	56,775 $280,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $11.11 $258,283 - $510,593	-45,958 Reduced 18.66%	200,364 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $2.54 Million - $4.26 Million	246,322 New	246,322 $2.66 Million
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $1.83 Million - $3.31 Million	-269,320 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $2.06 Million - $4.12 Million	269,320 New	269,320 $2.45 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $407,275 - $616,203	-15,792 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $249,674 - $429,807	9,892 Added 167.66%	15,792 $399,000
Q3 2020 Nov 16, 2020	BUY	$32.38 - $44.96 $191,042 - $265,264	5,900 New	5,900 $222,000
Q1 2020 May 15, 2020	SELL	$18.22 - $28.25 $994,739 - $1.54 Million	-54,596 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$24.82 - $31.4 $1.14 Million - $1.45 Million	46,049 Added 538.77%	54,596 $1.42 Million
Q3 2019 Nov 14, 2019	SELL	$26.11 - $32.99 $48,407 - $61,163	-1,854 Reduced 17.83%	8,547 $233,000
Q2 2019 Aug 14, 2019	SELL	$25.56 - $31.09 $66,430 - $80,802	-2,599 Reduced 19.99%	10,401 $279,000
Q1 2019 May 15, 2019	BUY	$24.82 - $32.54 $322,660 - $423,020	13,000 New	13,000 $376,000

Others Institutions Holding ALLO

# of Institutions

181

Shares Held

138M

Call Options Held

76.6K

Put Options Held

36.2K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $177M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Allogene Therapeutics, Inc. Transaction History